Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [8043]

FDA approves mirdametinib for adult and paediatric patients with neurofibromatosis type 1 who have symptomatic plexiform neurofibromas not amenable to complete resection

FDA approves mirdametinib for adult and paediatric patients with neurofibromatosis type 1 who have symptomatic...

$FDA approves brentuximab vedotin with lenalidomide and rituximab for relapsed or refractory large B-cell lymphoma$

FDA approves brentuximab vedotin with lenalidomide and rituximab for relapsed or refractory large B-cell lymphoma

AI unlocks genetic clues to personalise cancer treatment

AI unlocks genetic clues to personalise cancer treatment

Researchers unveil a novel strategy to combat melanoma brain metastases

Researchers unveil a novel strategy to combat melanoma brain metastases

Pancreatic cancer immune map provides clues for precision treatment targeting

Pancreatic cancer immune map provides clues for precision treatment targeting

Novel AI-driven FGFR2/3 inhibitor to overcome resistance tumour mutations

Novel AI-driven FGFR2/3 inhibitor to overcome resistance tumour mutations

Personalised cancer treatment using 3D bioprinting technology

Personalised cancer treatment using 3D bioprinting technology

Co-located cell types help drive aggressive brain tumors

Co-located cell types help drive aggressive brain tumors

Gene modification could improve cancer treatment's success rate

Gene modification could improve cancer treatment's success rate

Building better biomaterials for cancer treatments

Building better biomaterials for cancer treatments

More from ecancer